KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arbutus Biopharma (ABUS) Other Accumulated Expenses: 2013-2015

Historic Other Accumulated Expenses for Arbutus Biopharma (ABUS) over the last 1 years, with Jun 2015 value amounting to $745,000.

  • Arbutus Biopharma's Other Accumulated Expenses rose 169.93% to $745,000 in Q2 2015 from the same period last year, while for Jun 2015 it was $745,000, marking a year-over-year increase of 169.93%. This contributed to the annual value of $226,000 for FY2014, which is 71.57% down from last year.
  • Latest data reveals that Arbutus Biopharma reported Other Accumulated Expenses of $745,000 as of Q2 2015, which was down 40.45% from $1.3 million recorded in Q1 2015.
  • Arbutus Biopharma's 5-year Other Accumulated Expenses high stood at $1.3 million for Q1 2015, and its period low was $226,000 during Q4 2014.
  • Its 3-year average for Other Accumulated Expenses is $603,000, with a median of $510,000 in 2014.
  • Per our database at Business Quant, Arbutus Biopharma's Other Accumulated Expenses crashed by 71.57% in 2014 and then skyrocketed by 169.93% in 2015.
  • Arbutus Biopharma's Other Accumulated Expenses (Quarterly) stood at $795,000 in 2013, then plummeted by 71.57% to $226,000 in 2014, then surged by 169.93% to $745,000 in 2015.
  • Its Other Accumulated Expenses stands at $745,000 for Q2 2015, versus $1.3 million for Q1 2015 and $226,000 for Q4 2014.